Postmarketing Safety Study of Q/LAIV in Subjects 2 Through 49 Years of Age

Study identifier:MA-VA-MEDI3250-1115

ClinicalTrials.gov identifier:NCT01985997

EudraCT identifier:N/A

CTIS identifier:N/A

Study Complete

Official Title

Postmarketing Safety Study of Q/LAIV in Subjects 2 Through 49 Years of Age

Medical condition

Observation Safety

Phase

Phase 4

Healthy volunteers

Yes

Study drug

-

Sex

All

Actual Enrollment

95000

Study type

Observational

Age

N/A

Date

Study Start Date: 01 Jan 2014
Primary Completion Date: 01 Jul 2014
Study Completion Date: 01 Jul 2014

Study design

Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: Open Label
Primary Purpose: -

Verification:

Verified 01 Sept 2016 by MedImmune, LLC

Sponsors

MedImmune, LLC

Collaborators

-

Inclusion and exclusion criteria